-
sodium 5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-en-1-yl]-hexahydro-2H-cyclopenta[b]furan-3-ylidene]pentanoate
-
ChemBase ID:
156452
-
Molecular Formular:
C20H31NaO5
-
Molecular Mass:
374.44691
-
Monoisotopic Mass:
374.20691837
-
SMILES and InChIs
SMILES:
CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@H]2[C@@H]1/C(=C\CCCC(=O)[O-])/CO2)O)O.[Na+]
Canonical SMILES:
CCCCC[C@@H](C=C[C@H]1[C@H](O)C[C@H]2[C@@H]1/C(=C\CCCC(=O)[O-])/CO2)O.[Na+]
InChI:
InChI=1S/C20H32O5.Na/c1-2-3-4-8-15(21)10-11-16-17(22)12-18-20(16)14(13-25-18)7-5-6-9-19(23)24;/h7,10-11,15-18,20-22H,2-6,8-9,12-13H2,1H3,(H,23,24);/q;+1/p-1/t15-,16-,17+,18-,20+;/m0./s1
InChIKey:
OURCVRVJQMLUNA-LKBJAGTKSA-M
-
Cite this record
CBID:156452 http://www.chembase.cn/molecule-156452.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
sodium 5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-en-1-yl]-hexahydro-2H-cyclopenta[b]furan-3-ylidene]pentanoate
|
|
|
IUPAC Traditional name
|
sodium 5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-en-1-yl]-hexahydrocyclopenta[b]furan-3-ylidene]pentanoate
|
|
|
Synonyms
|
(5Z,9α,11α,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt
|
PGI2-Na
|
Prostacyclin sodium salt
|
Epoprostenol sodium salt
|
Prostaglandin I2 sodium salt
|
Epoprostenol 钠
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
4.398562
|
H Acceptors
|
5
|
H Donor
|
2
|
LogD (pH = 5.5)
|
1.1578689
|
LogD (pH = 7.4)
|
-0.59833145
|
Log P
|
2.2907794
|
Molar Refractivity
|
109.2534 cm3
|
Polarizability
|
37.96977 Å3
|
Polar Surface Area
|
89.82 Å2
|
Rotatable Bonds
|
10
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
82478
|
Biochem/physiol Actions Prostacyclin therapy improves hemodynamics in pulmonary arterial hypertension.1 |
PATENTS
PATENTS
PubChem Patent
Google Patent